STBT5:Ewing sarcoma: Difference between revisions

[pending revision][pending revision]
No edit summary
No edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 201: Line 201:
|Hyperdiploidy / numerical chromosomal gains
|Hyperdiploidy / numerical chromosomal gains
|Mitotic mis-segregation leading to whole-chromosome gains
|Mitotic mis-segregation leading to whole-chromosome gains
|Common
|Recurrent
|P
|P
|No
|No
Line 208: Line 208:
|Gain of odd-numbered chromosomes (e.g., 1, 7, 8, 12)  
|Gain of odd-numbered chromosomes (e.g., 1, 7, 8, 12)  
|Whole-chromosome gains arising from aneuploidy
|Whole-chromosome gains arising from aneuploidy
|Common
|Recurrent
|P (uncertain)
|P (uncertain)
|No
|No
Line 361: Line 361:


https://pubmed.ncbi.nlm.nih.gov/41301081/
https://pubmed.ncbi.nlm.nih.gov/41301081/
<references />
==Notes==
==Notes==
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the [[Leadership|''<u>Associate Editor</u>'']] or other CCGA representative.  When pages have a major update, the new author will be acknowledged at the beginning of the page, and those who contributed previously will be acknowledged below as a prior author.  
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the [[Leadership|''<u>Associate Editor</u>'']] or other CCGA representative.  When pages have a major update, the new author will be acknowledged at the beginning of the page, and those who contributed previously will be acknowledged below as a prior author.